(19)
(11)EP 3 381 287 A1

(12)EUROPEAN PATENT APPLICATION
published in accordance with Art. 153(4) EPC

(43)Date of publication:
03.10.2018 Bulletin 2018/40

(21)Application number: 16880237.9

(22)Date of filing:  29.12.2016
(51)International Patent Classification (IPC): 
A01N 59/20(2006.01)
B22F 1/02(2006.01)
B05D 1/02(2006.01)
(86)International application number:
PCT/CL2016/050082
(87)International publication number:
WO 2017/113033 (06.07.2017 Gazette  2017/27)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30)Priority: 29.12.2015 WO PCT/CL2015/050058

(71)Applicant: Atacamalab SPA
Providencia, Santiago (CL)

(72)Inventors:
  • GÓMEZ ÁLVAREZ, Marisol
    Santiago (CL)
  • RAMÍREZ MORA, Claudio Guillermo
    Santiago (CL)

(74)Representative: Manuel Illescas y Asociados, S.L.U. 
Príncipe de Vergara 197, Oficina 1°A
28002 Madrid
28002 Madrid (ES)

  


(54)ANTIMICROBIAL COMPOSITION FOR COATING SURFACES


(57) The present invention provides an antimicrobial composition for coating surfaces that provides a reduction of up to one hundred percent of the microbial activity on any type of frequently used substrates or surfaces, comprising a compound of micronized high-purity metallic copper particles. Moreover, a process for preparing the composition is provided.




Description

TECHNICAL FIELD



[0001] The present invention refers to an antimicrobial composition for coating surfaces that provides a reduction of up to one hundred percent of the microbial activity on any type of frequently used substrate or surface.

[0002] Moreover, a process for preparing the composition is provided.

BACKGROUND



[0003] It has been demonstrated by studies that healthcare-associated infections (HAIs) pose a public health problem given that they increase the morbidity and mortality of patients as well as the costs of care. It is estimated that 70,000 cases of hospital-acquired illnesses occur in Chile each year, which translates into a substantial cost for the country. Various studies point out that some of these HAIs originate from the transmission of pathogens via contact surfaces such as floors, walls, the side rails of beds, tables, etc. This problem provides an opportunity to innovate in the area of materials that have antimicrobial properties and that can replace conventional objects and surfaces and thereby have a great impact both in terms of health and economics.

[0004] In 2008, the Environmental Protection Agency (EPA) of the United States approved the registration of alloys of antimicrobial copper, confirming that they are beneficial to public health. These bactericidal properties of copper have already used in hospitals in Europe, the United States, and Chile, and it has been demonstrated that copperized surfaces reduce the pathogen load. However, metallic copper materials have certain drawbacks, such as oxidation, high cost, and difficult processability, which limits their implementation. The above drawbacks can be overcome by developing plastic (polymeric) materials and coatings (paints, varnishes, gels) to which antimicrobial properties are imparted through the incorporation of copper-based compounds.

[0005] In this way, various researchers have demonstrated, in applying the criteria established by the EPA (Environmental Protection Agency), that surfaces made of copper or alloys thereof are capable of eliminating 99.9% of pathogenic bacteria within hours, including methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli 0157:H7, Pseudomonas aeruginosa, Enterobacter aerogenes, Listeria monocytogenes, Salmonella entérica, Campylobacter jejuni, Legionella pneumophila, Clostridium difficile, and Mycobacterium tuberculosis.

[0006] Consistent findings under the conditions established by the EPA demonstrate the effectiveness of copper in the elimination of pathogenic bacteria at room temperature, in contrast to stainless steel. In these studies, copper quickly eliminated MRSA in 90 minutes, whereas no decrease in the bacterial concentration was observed with stainless steel after 6 hours (360 minutes). In bronze alloy, which contains 80% copper, MRSA was completely eliminated in 270 minutes.

[0007] Laboratory evidence documents the efficacy of copper in eliminating spores and vegetative forms of Clostridium difficile, a hospital pathogen associated with outbreaks of hospital-acquired infections with high mortality. These studies have shown elimination of spores after 24 hours of exposure to metallic copper, and another study shows that this effect starts after 30 minutes for vegetative forms and after 3 hours for spores, even in the presence of organic matter.

[0008] It is important to highlight that the bactericidal effect of copper surfaces is directly proportional to the concentration, with the maximum effect being achieved with metallic copper (99.9%) and being maintained in alloys containing at least 70% copper, and that, in these concentrations, it is also capable of inhibiting the formation of biofilms or multicellular colonies that are surrounded by extracellular polymers which they use to facilitate adhesion and the colonization of surfaces.

[0009] That was how, on 25 March 2008, with the support of the cumulative scientific evidence, the EPA registered copper as the first and only metal with antibacterial properties, authorizing the dissemination of significant concepts, including the fact that "copper surfaces eliminate 99.9% of bacterial pathogens after 2 hours of exposure" and certifying the fact that surfaces made of metallic copper and alloys thereof are natural antimicrobial agents, have long-lasting antimicrobial efficacy, have a self-disinfecting effect, and are superior to other coatings that are available on the market.

[0010] This registration authorizes the use of copper surfaces in hospital environments.

[0011] In addition, laboratory studies conducted by the Universidad de Chile have shown that copper surfaces not only kill bacteria by direct contact, but also impede the adhesion and inhibit the reproduction of clinical strains of the primary agents associated with hospital-acquired infections, including MRSA, multiresistant Klebsiella pneumoniae, and multiresistant Acinetobacter baumanii, in contrast to what is observed on stainless steel surfaces, to which bacteria adhere rapidly and very efficiently.

[0012] The precise mechanism explaining the antibacterial activity of copper has not been completely elucidated. One crucial element of the antibacterial activity is the ability of copper to give off and accept electrons in a continuous process. Some studies suggest that, in high concentrations, copper has a toxic effect on bacteria due to the release of hydroperoxide radicals; the copper ions may potentially substitute ions that are essential to bacterial metabolism, such as iron, initially interfering with the function of the cell membrane and then, in the cytoplasm, altering the protein synthesis, either by inhibiting the formation of proteins or causing the synthesis of dysfunctional proteins, thus altering the activity of enzymes that are essential to bacterial metabolism.

[0013] Copper has also exhibited the ability to destroy viruses that are of great medical importance, including the influenza A virus and the human immunodeficiency virus, HIV, in concentrations as low as 0.16 to 1.6 mM. The development of filters with copper oxide has made possible to efficiently eliminate the risk of the transmission of HIV via fluids. The mechanisms involved in the antiviral activity are the inactivation of a protease enzyme that is important for viral replication and the damaging of the phospholipid shell.

[0014] On the other hand, evidence also exists of the antifungal activity of copper. For example, fungi species, including Candida albicans, are inhibited in their growth and then destroyed, when they come into contact with copper surfaces. The antifungal activity probably occurs by means of a complex process called "death by contact," in which the cytoplasmic membrane is damaged and becomes depolarized, facilitating the entry of copper ions into the cell, enhancing the damage and, secondarily, producing an increase in the oxidative stress without apparent damage.

[0015] In the prior art, it is possible to find coatings and compositions describing the use of copper, such as document GB 2466805, which describes a method for the deposition of a layer with antibacterial properties onto a substrate comprising chemical vapor deposition at atmospheric pressure using a flame as a reaction energy source; wherein a second material for stabilizing, protecting, and controlling the release of the metal is also deposited, wherein the metal and the second material are deposited simultaneously or sequentially.

[0016] It is also possible to find compositions with antimicrobial agents against gram-positive and gram-negative microorganisms that correspond to nanoparticles of copper and nanoparticles of copper oxide, as described in the publication RU 2416435, in which the antimicrobial agents according to the invention are characterized by specific particle sizes and phase compositions. The nanoparticles contain 67 to 96% of copper and 4 to 33% of CuO. The nanoparticles of copper oxide contain crystalline copper, CuO and Cu2O.

[0017] As regard to the use of nanoparticles and polymers, the publication WO 2014030123 relates to polymeric materials, particularly thermoplastic or resins with antifouling, biocidal, antiviral, and antimicrobial properties, wherein the antimicrobial property is given by the controlled and maintained release over time of elements or compounds with antimicrobial properties comprising nanoparticles from 4 to 500 nanometers, more preferably from 10 to 80 nanometers, of an element or inorganic compound with antimicrobial and biocidal properties, wherein the nanoparticles are pre-treated to improve final dispersion and are completely embedded in the thermoplastic resin and do not protrude from the surface of the resin, and wherein the nanoparticles of the element or inorganic compound with antimicrobial properties form a secondary structure, called agglomerate, ranging in size from 0.1 to 100 micrometers, wherein the ratio in weight between nanoparticles of the element or inorganic compound and the thermoplastic and/or thermostable resin and/or organic coating of painting type is between 1 and 80% by weight, and wherein said secondary structures are homogeneously dispersed in the resin.

[0018] Therefore, products that are based on the antimicrobial activity of copper for use in marine transport are known but, said products are highly toxic to humans.

[0019] By significantly reducing the bacterial load, copper enables the enhancement of aseptic conditions in clinical enclosures, in schools, and in public spaces in general, helping to reduce cross-contamination in food-related processes. Notwithstanding the above, what is certain is that no composition with copper particles is known that is capable of reducing the microbial load by one hundred percent in one hour.

[0020] The current limitations on the use of copper on surfaces lie in the high cost of using plates of metallic copper that do not have the appropriate dimensions for every surface, which results in high installation costs as well. In the case of the polymeric resins or coatings, the natural wear from use gradually eliminates the copper content of the surfaces, reducing their antimicrobial capacity.

DEFINITIONS



[0021] Micrometric metallic copper particles: Refers to particles whose size is no less than 1 micrometer and no more than 1000 micrometers. This is to differentiate them from nanoparticles and pieces of metal that are larger than 1000 microns.

[0022] Nanometric metallic copper particles: Refers to particles with size of 1 nanometer to 250 microns.

[0023] 100% solid resin: Refers to binding compounds that are free of volatile organic solvents.

BRIEF DESCRIPTION OF THE FIGURES



[0024] 

Fig. 1: Table showing the distribution of particles in the composition once applied to the surface.

Fig. 2: Initial inoculum and CFU count in an assay of antibacterial activity against E. coli O157:H7. [A] Initial inocula of 1.95 x 107 bacteria (assay no. 1, left) and of 2.4 x 107 bacteria (assay no. 2, right) [B] Viable bacterial count for each sample. Experimental and technical duplicates are shown. The dilution factor is shown as 0, -1, -2, -3, -4, and -5.

Fig. 3: Initial inoculum and CFU count for assay of antibacterial activity against S. aureus. [A] Initial inocula of 4.35 x 107 bacteria (assay no. 1, left) and of 1.5 x 107 bacteria (assay no. 2, right) [B] Viable bacterial count for each sample. Experimental and technical duplicates are shown. The dilution factor is shown as 0, -1, -2, -3, -4, and -5.


BRIEF DESCRIPTION OF THE INVENTION



[0025] The present invention relates to an antimicrobial composition for coating surfaces and to a process for preparing said composition intended to address the problem of the possible shortcomings in the time of response, efficiency, and efficacy of the asepsis of surfaces that may have microbial activity.

[0026] The composition and process are based on the combination of copper particles and binding agents that enable the coating to adhere to the substrate to which it is applied with the purpose of obtaining a covered surface that is capable of eliminating the microbial activity on the surfaces exposed to the composition by up to one hundred percent.

[0027] The composition operates in three phases or stages that interact to facilitate the antimicrobial action of the copper particles, enabling the surfaces to which it is applied to be used without the risk of contamination or contagion by microbes.

DETAILED DESCRIPTION OF THE INVENTION



[0028] The invention corresponds to an antimicrobial composition for coating surfaces, composed of micronized and micrometric high-purity metallic copper, and optionally nanometric metallic copper, with a distribution of particles of various shapes, sizes, and proportions in a fluid vehicle to be applied cold and hardened by polymerization mechanisms (see Figure 1).

[0029] The particles that are used are of various shapes and sizes:
  • amorphous
  • spherical,
  • filamentous, and
  • laminar.


[0030] The size distribution ranges from 1 micrometer to 50 microns. The diversity of the shapes and sizes of the metallic particles allows obtaining surfaces having up to 100% antimicrobial protection, as shown in Fig. 1.

[0031] Unlike other coating-type products that contain particles, nanoparticles, or pigmentations of copper and other active substances that act as biocides or bactericides, the saturation of shapes and dimensions of present invention ensures a permanent antimicrobial action over time based on high-density metallic copper, which renders it distinctive and differentiating, since it is equivalent or superior in its functionality to the application of a metallic copper coating.

[0032] The antimicrobial action of the composition according to the present invention operates in three phases or stages that interact with one another:
  • The first phase corresponds to the mass of copper that carries the greatest ionic charge. This phase tends to be located in the lower zone that is in contact with the surface to be coated, since by gravity, the largest or most massive particles travel to the bottom of the coating or to the interior of the coating.
  • The second phase corresponds to the surface of the coating where the laminar particles are preferably located and optionally, part of the metallic copper nanoparticles, that float in contact with the surface and the internal medium of the coating. These particles have a low charge but greater surface exposure towards the exterior of the coating.
  • The third phase comprises the spherical, amorphous, filamentous, dendritic particles and nanoparticles of metallic copper that form the network for ion contact and transmission with the aid of the polymer, which acts as a binding vehicle for the copper particles. These particles have little mass and little surface area, but they act as a bridge of communication between the surface laminar particles and the particles with a high charge contribution.


[0033] This combination of different types of copper particles and the polymer thus facilitate the antimicrobial action of the copper by facilitating the ionic capacity of the material, thus enabling antimicrobial action to be achieved that is up to 100% effective, making it possible for the surfaces to which it is applied to be used without the risk of contamination or contagion by microbes. This improved ionic effect is therefore due to the geometry of the particles and the distribution thereof in combination with the polymer.

[0034] As regards the copper content of the composition, it is greater or equal to 30% and up to 90% with respect to the weight of the final composition.

[0035] The polymer corresponds to a binding agent hardened by crosslinking, and capable of adhering well to the surface to be coated or substrate. The use of a polymer allows obtaining a coating that easily covers the entire shape or geometry of the substrate.

[0036] The polymers to be used include epoxy coatings such as polyamide epoxy resin, polyurethane, and polymethyl methacrylate, among others.

PROCESS FOR PREPARATION:



[0037] The process described below is illustrative and thus, the manner in which the particles are made described accordingly, does not limit the type of particles used in present invention.

[0038] The particles are prepared by means of thermal induction melting processes and subsequent pulverization in inert gas media at low temperature in order to prevent metal oxidation. Spherical and hemispherical particles are obtained in this way which are sieved in order to obtain particles in a granulometric range between 1 micron and 50 microns, with a mean of 25 microns.

[0039] A fraction of these particles, preferably between 10 and 20% of such particles, is separated and treated in ball and roller mills in order to obtain the laminar and amorphous particles. The filamentous particles have a weight of up to 10% of the total weight of the particles and are obtained independently from the other types of particles by means of techniques using microwires obtained by melting copper inside glass capillaries, which are wound on a spool from which they are cut in lengths of less than 50 microns.

[0040] To produce the coating, premixing is performed only of the laminar particles, which provide the characteristic copper color, stabilized with the zinc additive, and with the resin, which contains thixotropic additive of the pyrogenic siliceous type. The nanometric particles, and the larger-sized amorphous, spherical and hemispherical particles are incorporated subsequently and only at the moment the product is prepared and within the "mixing lifetime" of the resin with the hardener, for which reason they are delivered in an accompanying container. This finally results in a product with 3 components - the pigmented base, hardener, and system-activating particles.

MANNER OF APPLICATION AND MECHANISM OF ACTION



[0041] To apply the composition, the first step is to make a preparation and clean the substrate to which the composition is to be applied. The resin base, which contains the thixotropic and stabilizing additives of Zn phosphate with the larger-sized activator particles, is then mixed, and then it is mixed with the hardening reagent. The composition is applied using airless equipment (airless projection).
The product that is applied contains copper particles that float in contact with the surface and the internal medium of the coating.

[0042] Once the surface to which the coating was applied has been cleared for use, an electrostatic activation process is performed after which it begins to release its antimicrobial capacity.

[0043] The precise mechanism explaining the antibacterial activity of copper has not been completely elucidated. However, one crucial element of the antibacterial activity is the ability of copper to give off and accept electrons in a continuous process.

[0044] Some studies suggest that, in high concentrations, copper has a toxic effect on bacteria due to the release of hydroperoxide radicals; the copper ions may potentially substitute ions that are essential to bacterial metabolism, such as iron, initially interfering with the function of the cell membrane and then, in the cytoplasm, altering the protein synthesis, either by inhibiting the formation of proteins or causing the synthesis of dysfunctional proteins, thus altering the activity of enzymes that are essential to bacterial metabolism.

[0045] The sequence in which the copper particles act on the bacteria is:
  1. 1. Copper ions are released from copper surfaces, penetrating the bacterial cell and causing damage to the cytoplasmic membrane.
  2. 2. Rupturing of the cytoplasmic membrane promotes the entry of the copper ions, which results in dysfunction of the membrane and an increase in the oxidative stress.
  3. 3. An alteration of the protein synthesis is produced in the cytoplasm, along with functional damaging of the essential enzymes.
  4. 4. Cell death and degradation of bacterial DNA.

TECHNICAL ADVANTAGES



[0046] Since it micrometric copper, it is not toxic to users who are exposed to the coated surfaces. In reference to the use of nanometric particles, those are also made of metallic copper.

[0047] The resulting coating attains high levels of wear resistance and complete adhesion to a variety of substrates, offering 100% antibacterial protection against the bacteria defined in the standard or protocol of the Environmental Protection Agency (EPA).

[0048] The composition according to the present invention contains only binders and metallic copper particles, which renders it safe in comparison to alternative products, which contain active ingredients that are possibly toxic and solvents that limit the application thereof in closed spaces and are not safe for use on surfaces that are in direct contact with users.

[0049] Another advantage lies in the fact that application can be performed at low temperature, making it suitable for all surface types and reducing the application costs in comparison to products with a similar copper content, which are applied at high temperatures.

PREFERRED EMBODIMENT OF THE INVENTION



[0050] Although the resin contains thixotropic additives, it was found that, due to the density and shape of the larger-sized spherical, amorphous and filamentous particles, they sediment out a few days after having been incorporated; for this reason, the resin base is delivered with thixotropic additives of pyrogenic silica and Zn phosphate additives that stabilize the oxidation of Cu together with the laminar particles in a proportion of 1 to 3%. The larger size amorphous particles and spherical particles on the order of 50 microns are delivered separately in order to be incorporated only at the time of application simultaneously with the hardener; wherein between 30 and 90% by weight of spherical particles of high-purity metallic copper are incorporated. The lifetime of the mix is less than one hour at 20 °C, with the lifetime decreasing at higher temperatures.

[0051] In a preferred embodiment of the invention, the particles used in the first phase are larger size amorphous particles, providing increased adherence in comparison with regular spherical or semispherical particles.

EXAMPLES


Example 1: QUANTIFICATION OF THE ANTIBACTERIAL ACTIVITY OF SAMPLES WITH "LIQUID COPPER" COATING (LABORATORY REPORT)



[0052] The following data are from the analyses performed on 25 September 2015 by David Montero, M.Sc., Ph.D. (c) at the inventors' request.

Methodology: Protocol for the analysis of antibacterial activity on solid surfaces that contain copper.



[0053] The protocols described by the United States Environmental Protection Agency (EPA) were used in order to determine the disinfectant efficacy of surfaces containing copper,1 with slight modifications.

[0054] Briefly, the problem samples (type A: A1, A2, A3; type B: B1, B2, B3) were sterilized with sodium hypochlorite (20% v/v) and ethanol (70% v/v) for 24 hours. Each sample was then placed in a plastic petri dish and allowed to dry in a laminar flow chamber for 1 hour, with UV radiation being applied to each side for 15 minutes.

[0055] Each sample was evaluated using an inoculum of Escherichia coli O157:H7 (ATCC 43895) or Staphylococcus aureus (ATCC 29213) containing between 1 x 107 and 5 x 107 bacteria.

[0056] The inocula of E. coli and S. aureus were obtained by growing the bacteria overnight on Luria Bertani (LB) broth and brain heart infusionbroth, respectively. One-hour post-inoculation, each sample was washed with 1 ml of saline phosphate buffer solution (PBS), and the bacterial count was performed by means of dilution series.

[0057] The bacterial count for E. coli and S. aureus was performed by plating 10 µl of each dilution on LB agar and Baird Parker agar, respectively.

[0058] The LB agar and Baird Parker agar plates were incubated at 35 ± 2 °C for 24 and 48 hours, respectively. The plates containing between 10 and 200 colony-forming units (CFUs) were recorded. The evaluation was performed in experimental and technical duplicate.

Data analysis:



[0059] Number of viable bacteria per sample:

where

N = number of viable bacteria recovered per test specimen

C = average count for samples in duplicate

D = dilution factor for each plate counted

V = volume of PBS added for each specimen, in ml

V2 = plated volume, in ml



[0060] Percentage reduction:

where
  1. a = average initial inoculum or number of viable bacteria recovered in the control samples
  2. b = average number of viable bacteria recovered in the problem samples

Results


1. Antibacterial activity against E. coli O157:H7


Inoculum used:



[0061] 

Assay 1.





Assay 2.





[0062] For the first assay, an inoculum of 1.95 x 107 bacteria (Fig. 2A, left), and an inoculum of 2.4 x 107 bacteria was used for the second assay (Fig. 2A, right)

Viable bacterial count per sample:



[0063] In all of the assays performed with type-A1-3 and type-B1-3 samples, no viable bacteria were observed after one hour of contact (Fig. 2B). Consequently, the reduction in the bacterial load was 100%.

2. Antibacterial activity against S. aureus


Inoculum used:



[0064] 

Assay 1.



Assay 2.





[0065] For the first assay, an inoculum of 4.35 x 107 bacteria (Fig. 3A, left), and an inoculum of 1.5 x 107 bacteria was used for the second assay (Fig. 3A, right)

Viable bacterial count per specimen:



[0066] In all of the assays performed with type-A1-3 and type-B1-3 samples, no viable bacteria were observed after one hour of contact (Fig. 2B). Consequently, the reduction in the bacterial load was 100%.

[0067] The results obtained suggest that the type-A and type-B samples can be preliminarily categorized as having disinfectant effect against E. coli O157:H7 and S. aureus when the described methodological protocol is implemented. More studies and replications are needed to corroborate the results obtained.

References



[0068] 1 United States Environmental Protection Agency (EPA). 2014. Protocol for the Evaluation of Bactericidal Activity of Hard, Non-porous Copper/Copper-Alloy Surfaces. EPA, Washington, DC.


Claims

1. An antimicrobial composition for coating surfaces, characterized in that it comprises a compound of micronized high-purity metallic copper particles, and a fluid vehicle to be applied cold.
 
2. A composition according to claim 1, characterized in that the compound of micronized metallic copper particles has a distribution of particles of different shapes, sizes, and proportions.
 
3. A composition according to claim 1, characterized in that the fluid vehicle compound is a polymer that is hardened by mechanisms of polymerization.
 
4. A composition according to claims 1 or 2, characterized in that the compound of micronized metallic copper particles comprises particles of spherical, filamentous, amorphous, and laminar shapes.
 
5. A composition according to claims 1 to 4, characterized in that the size distribution of the copper particles ranges from 1 nanometer to 50 microns.
 
6. A composition according to claims 1 to 5, characterized in that the copper content in the composition is between 30% and 90% with respect to weight of the final composition.
 
7. A composition according to any one of the preceding claims, characterized in that the polymer is free of solvent after it is hardened.
 
8. The composition as set forth in claim 1, characterized in that the polymer is selected from among inorganic resins such as polyamide epoxy, polyurethane, polymethyl methacrylate, among others.
 
9. A process for preparing an antimicrobial composition for coating surfaces, characterized in that it comprises the steps of:

a. preparing spherical and hemispherical particles of micronized high-purity metallic copper;

b. separating a fraction of the spherical and hemispherical particles, treating them in mills, and obtaining laminar and amorphous particles;

c. obtaining filamentous particles;

d. mixing only the laminar particles and a resin; and

e. incorporating the larger-sized particles into the previous mixture at the time of the preparation of the product and within the "mixing lifetime" of the resin with the hardener.


 
10. A process according to claim 9, characterized in that the spherical and hemispherical particles are prepared by means of thermal induction melting processes and subsequent pulverization in inert gas media at low temperature in order to prevent metal oxidation.
 
11. A process according to claim 9 or 10, characterized in that the particles obtained are sieved in order to obtain a granulometric range lower than 50 microns.
 
12. A process according to claim 9, characterized in that the mills used in step (b) are ball and roller mills.
 
13. A process according to claim 9, characterized in that the filamentous particles are prepared by techniques using microwires.
 
14. A process according to claim 9, characterized in that the filamentous particles are prepared by melting copper in glass capillaries.
 
15. A process according to claim 9, characterized in that Zn phosphate additive is also added to the mixture described in step (d).
 
16. A process according to claim 9, characterized in that the resin contains a thixotropic additive of the pyrogenic siliceous type.
 
17. A method for applying an antimicrobial composition for coating surfaces, characterized in that it is applied by means of airless projection or by manual means.
 
18. A method as set forth in claim 17, characterized in that, once applied and subsequent to drying, the coating is activated by electrostatic means.
 




Drawing













Search report
















Cited references

REFERENCES CITED IN THE DESCRIPTION



This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.

Patent documents cited in the description